Brain-Computer Interfaces for Treatment of Focal Dystonia.
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
20
06
2022
received:
28
03
2022
accepted:
19
07
2022
pubmed:
11
8
2022
medline:
16
9
2022
entrez:
10
8
2022
Statut:
ppublish
Résumé
Task-specificity in isolated focal dystonias is a powerful feature that may successfully be targeted with therapeutic brain-computer interfaces. While performing a symptomatic task, the patient actively modulates momentary brain activity (disorder signature) to match activity during an asymptomatic task (target signature), which is expected to translate into symptom reduction.
Identifiants
pubmed: 35947366
doi: 10.1002/mds.29178
pmc: PMC9474652
mid: NIHMS1830713
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1798-1802Subventions
Organisme : NIDCD NIH HHS
ID : R01 DC012545
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC019353
Pays : United States
Informations de copyright
© 2022 International Parkinson and Movement Disorder Society.
Références
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:3058-3061
pubmed: 33018650
Mov Disord. 2014 Aug;29(9):1141-50
pubmed: 24925463
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:3337-40
pubmed: 21097230
PLoS Biol. 2018 May 10;16(5):e2003787
pubmed: 29746465
BMC Neurosci. 2014 Sep 01;15:103
pubmed: 25179667
Brain. 2017 Dec 1;140(12):3179-3190
pubmed: 29087445
Nat Commun. 2018 Jun 20;9(1):2421
pubmed: 29925890
IEEE Trans Neural Syst Rehabil Eng. 2013 May;21(3):474-80
pubmed: 23060345
J Neurosci. 2009 Aug 5;29(31):9740-7
pubmed: 19657027
Ann Neurol. 1998 Sep;44(3):303-12
pubmed: 9749595
Hum Brain Mapp. 2020 Aug 15;41(12):3253-3265
pubmed: 32311207
Commun Biol. 2021 Sep 23;4(1):1055
pubmed: 34556793
Nat Rev Neurosci. 2017 Feb;18(2):86-100
pubmed: 28003656
Ann Clin Transl Neurol. 2018 Mar 25;5(5):651-663
pubmed: 29761128
Neurology. 2021 Mar 16;96(11):e1551-e1560
pubmed: 33504639
Mov Disord. 2019 Apr;34(4):555-563
pubmed: 30840778
Cereb Cortex. 2017 Feb 1;27(2):1203-1215
pubmed: 26679193
Can J Neurol Sci. 1993 Aug;20(3):177-83
pubmed: 8221380
IEEE Trans Haptics. 2016 Oct-Dec;9(4):523-535
pubmed: 27552765
Lancet. 2013 Feb 16;381(9866):557-64
pubmed: 23253623
Brain. 1995 Dec;118 ( Pt 6):1473-84
pubmed: 8595478
NeuroRehabilitation. 2009;25(1):19-27
pubmed: 19713616
Mov Disord. 2019 Nov;34(11):1616-1628
pubmed: 31591783
Brain. 1985 Jun;108 ( Pt 2):463-83
pubmed: 4005532
BMC Neurol. 2019 Jun 24;19(1):137
pubmed: 31234792
Neuroscience. 2014 Feb 28;260:23-35
pubmed: 24333801
Neurology. 2019 Apr 16;92(16):e1843-e1851
pubmed: 30918091
Arch Phys Med Rehabil. 2015 Mar;96(3 Suppl):S1-7
pubmed: 25721542
Neurology. 2020 Mar 24;94(12):526-537
pubmed: 32098856
J Clin Mov Disord. 2016 Dec 19;3:19
pubmed: 28031858
Nat Rev Dis Primers. 2018 Sep 20;4(1):25
pubmed: 30237473
Hum Brain Mapp. 2016 Dec;37(12):4363-4375
pubmed: 27466043
Ann Neurol. 2013 Sep;74(3):449-57
pubmed: 23852650
Handb Clin Neurol. 2020;168:15-23
pubmed: 32164849
Front Neurosci. 2015 Jun 12;9:217
pubmed: 26124702
Nature. 2021 May;593(7858):249-254
pubmed: 33981047
Handb Clin Neurol. 2013;116:167-87
pubmed: 24112893
Speech Commun. 2010 Apr 1;52(4):367-379
pubmed: 20204164
Proc Natl Acad Sci U S A. 2019 Dec 23;:
pubmed: 31871144
Mov Disord. 2021 Jan;36(1):196-205
pubmed: 32979238